EV/EBITDA
0.02
+0.01+100.00%
Thu, 28 Nov 2024 00:59:49 GMT
Summary:
CNS Pharmaceuticals EV/EBITDA is currently 0.02, with a rise of +0.01 (+100.00%) during the most recent trading day. Over the past year, it has increased by +0.62 (+103.33%). CNSP EV/EBITDA is now -96.23% below its all-time high of 0.53.CNSP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNSP EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +100.0% |
| 1 m1 month | 0.0% |
| 3 m3 months | +107.7% |
| 6 m6 months | +118.2% |
| ytdytd | +104.9% |
| 1 y1 year | +103.3% |
| 5 y5 years | +100.2% |
CNSP EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 0.10 | -80.0% | -0.02 | +200.0% |
| 3 m | 3 months | 0.18 | -88.9% | -0.26 | +107.7% |
| 6 m | 6 months | 0.18 | -88.9% | -0.32 | +106.3% |
| 1 y | 1 year | 0.18 | -88.9% | -0.65 | +103.1% |
| 3 y | 3 years | 0.53 | -96.2% | -1.71 | +101.2% |
| 5 y | 5 years | 0.53 | -96.2% | -19.60 | +100.1% |
| alltime | all time | 0.53 | -96.2% | -19.60 | +100.1% |
CNS Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 0.02(-104.9%) |
| 2023 | -0.41(-207.9%) |
| 2022 | 0.38(-136.9%) |
| Date | Value |
|---|---|
| 2021 | -1.03(-66.3%) |
| 2020 | -3.06(-79.8%) |
| 2019 | -15.12 |
FAQ
- What is CNS Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for CNS Pharmaceuticals?
- What is CNSP EV/EBITDA year-to-date change?
- What is CNS Pharmaceuticals EV/EBITDA year-on-year change?
What is CNS Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of CNSP is 0.02
What is the all time high EV/EBITDA for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high EV/EBITDA is 0.53
What is CNSP EV/EBITDA year-to-date change?
CNS Pharmaceuticals EV/EBITDA has changed by +0.43 (+104.88%) since the beginning of the year
What is CNS Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, CNSP EV/EBITDA has changed by +0.62 (+103.33%)